These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15372476)

  • 21. Expression of matrix metalloproteinase 2 and its tissue inhibitor in oral squamous cell carcinoma.
    Gao ZB; Duan YQ; Zhang L; Chen DW; Ding PT
    Int J Mol Med; 2005 Oct; 16(4):599-603. PubMed ID: 16142392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
    Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
    Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer.
    Murray GI; Duncan ME; O'Neil P; McKay JA; Melvin WT; Fothergill JE
    J Pathol; 1998 Jul; 185(3):256-61. PubMed ID: 9771478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of L-type amino acid transporter 1 (LAT1) in esophageal carcinoma.
    Kobayashi H; Ishii Y; Takayama T
    J Surg Oncol; 2005 Jun; 90(4):233-8. PubMed ID: 15906366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of MMP9 and CD147 in invasive squamous cell carcinoma of the uterine cervix and their implication.
    Yu W; Liu J; Xiong X; Ai Y; Wang H
    Pathol Res Pract; 2009; 205(10):709-15. PubMed ID: 19541433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and clinical significance of CD147 in genitourinary carcinomas.
    Han ZD; He HC; Bi XC; Qin WJ; Dai QS; Zou J; Ye YK; Liang YX; Zeng GH; Zhu G; Chen ZN; Zhong WD
    J Surg Res; 2010 May; 160(2):260-7. PubMed ID: 19286191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Profiling gene expression ratios of paired cancerous and normal tissue predicts relapse of esophageal squamous cell carcinoma.
    Ishibashi Y; Hanyu N; Nakada K; Suzuki Y; Yamamoto T; Yanaga K; Ohkawa K; Hashimoto N; Nakajima T; Saito H; Matsushima M; Urashima M
    Cancer Res; 2003 Aug; 63(16):5159-64. PubMed ID: 12941848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
    Asano T; Tada M; Cheng S; Takemoto N; Kuramae T; Abe M; Takahashi O; Miyamoto M; Hamada J; Moriuchi T; Kondo S
    J Surg Res; 2008 May; 146(1):32-42. PubMed ID: 17543340
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis.
    Miyata Y; Iwata T; Ohba K; Kanda S; Nishikido M; Kanetake H
    Clin Cancer Res; 2006 Dec; 12(23):6998-7003. PubMed ID: 17145820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
    Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
    Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expressions of CD147 and matrix metalloproteinase-2 in breast cancer and their correlations to prognosis].
    Zhou S; Liu C; Wu SM; Wu RL
    Ai Zheng; 2005 Jul; 24(7):874-9. PubMed ID: 16004819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
    Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma.
    Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S
    Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD147 expression as a significant prognostic factor in differentiated thyroid carcinoma.
    Tan H; Ye K; Wang Z; Tang H
    Transl Res; 2008 Sep; 152(3):143-9. PubMed ID: 18774544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
    Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions.
    Sun J; Hemler ME
    Cancer Res; 2001 Mar; 61(5):2276-81. PubMed ID: 11280798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The matrix metalloproteinase system in oral squamous cell carcinoma.
    Baker EA; Leaper DJ; Hayter JP; Dickenson AJ
    Br J Oral Maxillofac Surg; 2006 Dec; 44(6):482-6. PubMed ID: 16338034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells.
    Reimers N; Zafrakas K; Assmann V; Egen C; Riethdorf L; Riethdorf S; Berger J; Ebel S; Jänicke F; Sauter G; Pantel K
    Clin Cancer Res; 2004 May; 10(10):3422-8. PubMed ID: 15161697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.
    Dhar DK; Hattori S; Tonomoto Y; Shimoda T; Kato H; Tachibana M; Matsuura K; Mitsumoto Y; Little AG; Nagasue N
    Ann Thorac Surg; 2007 Apr; 83(4):1265-72. PubMed ID: 17383324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.